Results 11 to 20 of about 425,098 (322)

Teixobactin: A Novel Antibiotic in Treatment of Gram Positive Bacterial Infections [PDF]

Journal of Clinical and Diagnostic Research, 2015
Sir, Antimicrobial resistance have emerged as a serious concern worldwide. In spite of the best effort in developing novel antimicrobial agents employing advanced techniques like computer-aided drug design, proteomics, genomics, combinatorial synthesis and high- throughput screening, there is lack of newer antibiotics in the process of development ...
Arunava Kali
doaj   +4 more sources

Correction: Continuous versus intermittent vancomycin infusions in critically ill children with gram-positive bacterial infections: a randomized controlled trial [PDF]

BMC Infect Dis
Yahui Wu, Shuang Liu, Chong Shi, M Zhang, Jing Chen, Xiaolan Huang, Xiaodai Cui, Siyuan Huang, Jingrong Fan, Dong Qu, Lihui Meng   +10 more
openalex   +2 more sources

Modeling Approach to Optimizing Dose Regimen of Vancomycin for Chinese Pediatric Patients with Gram-Positive Bacterial Infections [PDF]

Front Pharmacol, 2021
Kai Shen, Yaxin Fan, Minjie Yang, Yuancheng Chen, Jinhao Tao, Guoping Lü, Hong Zhang, Qiwei Huang, Jing Zhang   +8 more
openalex   +2 more sources

<p>Vancomycin Dosage and Its Association with Clinical Outcomes in Pediatric Patients with Gram-Positive Bacterial Infections</p> [PDF]

Risk Manag Healthc Policy, 2020
Sooyoung Shin, Hyun Joo Jung, Sang‐Min Jeon, Young-Joon Park, Jung‐woo Chae, Hwi‐yeol Yun   +5 more
openalex   +3 more sources

Strategies for the Successful Treatment of Gram-Positive Bacterial Infections [PDF]

Clinical Infectious Diseases, 2000
Jack S. Remington
  +5 more sources

P-1102. Real-World Effectiveness of Dalbavancin for Invasive Gram-Positive Bacterial Infections [PDF]

Open Forum Infect Dis
Jake Crocker, Caroline Derrick, Julie Ann Justo, P. Brandon Bookstaver, Ismaeel Yunusa, Bruce M Jones, Bryan P. White, Joseph Sassine, Madeline Belk, Morgan Pizzuti   +9 more
openalex   +2 more sources

Effect of low vs. high vancomycin trough level on the clinical outcomes of adult patients with sepsis or gram-positive bacterial infections: a systematic review and meta-analysis [PDF]

BMC Infect Dis
Subhash Chander, Roopa Kumari, Hong Yu Wang, Yaqub Nadeem Mohammed, Om Parkash, Sindhu Lohana, FNU Sorath, ABHI LOHANA, FNU Sadarat, Sheena Shiwlani   +9 more
openalex   +2 more sources

Gram-Positive Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership Group [PDF]

Clin Infect Dis, 2016
Sarah B. Doernberg, Thomas P. Lodise, Joshua T. Thaden, José M. Munita, Sara E. Cosgrove, César A. Arias, Helen W. Boucher, G. Ralph Corey, Franklin D. Lowy, Barbara E. Murray, Loren G. Miller, Thomas L Holland   +11 more
openalex   +2 more sources

Treatment of erythrasma: A double-blinded randomized controlled trial on the clinical application of clotrimazole and sertaconazole [PDF]

Journal of Research in Clinical Medicine, 2020
Introduction: Topical clotrimazole and sertaconazole may be effective in the treatment of erythrasma, a superficial skin infection developed by a group of aerobic microorganisms. This study aimed to compare the effect of clotrimazole and sertaconazole on
Hamideh Herizchi Ghadim, Sevil Hekmatshoar, Aida Salman Mohajer, Mohammad-Salar Hosseini   +3 more
doaj   +1 more source

Characteristics and risk factors of secondary bacterial infections in COVID-19 patients

Antimicrobial Stewardship & Healthcare Epidemiology, 2023
Objective: To describe the characteristics and find out risk factors of COVID-19 patients infected with different categories of bacteria. Design: Case-control.
Guangjie Wu, Jianhua Lu, Dong Liu, Yan He   +3 more
doaj   +1 more source